Codexis Stock (NASDAQ: CDXS) stock price, news, charts, stock research, profile.
Open | $3.580 |
Close | $3.530 |
Volume / Avg. | 439.858K / 602.693K |
Day Range | 3.370 - 3.625 |
52 Wk Range | 1.450 - 4.910 |
Market Cap | $254.007M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 3.83% |
Days to Cover | 6.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Codexis (NASDAQ: CDXS) through any online brokerage.
Other companies in Codexis’s space includes: Harvard Bioscience (NASDAQ:HBIO), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR), Quanterix (NASDAQ:QTRX) and Conduit Pharmaceuticals (NASDAQ:CDT).
The latest price target for Codexis (NASDAQ: CDXS) was reported by Benchmark on Friday, May 3, 2024. The analyst firm set a price target for 9.00 expecting CDXS to rise to within 12 months (a possible 150.00% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Codexis (NASDAQ: CDXS) is $3.6 last updated May 7, 2024 at 6:24 PM EDT.
There are no upcoming dividends for Codexis.
Codexis’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Codexis.
Codexis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.